Answers are grounded in this paper and cite their sources.
The era of apathy in the face of the HIV pandemic may be ending. A global groundswell of grassroots AIDS activism focusing on treatment access has challenged the inertia of policymakers, public health experts, and private industry. The campaign has won significant price concessions from the large pharmaceutical companies and forced changes in US trade policies that opposed efforts to produce generic versions of AIDS-related drugs. As prices dropped, the possibility of treatment converted the public perception of AIDS from an insolvable tragedy to a moral issue and an opportunity to save lives. Most important, the prospect of treatment that can alleviate suffering and postpone death has instilled hope in millions of individuals and mobilized the broader society in some of the most severely affected countries.
No takes yet. Share an insight, caveat, or question.
Alan Berkman (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: